A. ULUSLARARASI HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER:
1. MiRiLi C, GÜNEY IB, PAYDAS S, et al.(2019). Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET–CT metabolic parameters in small cell lung cancer (SCLC). International Journal of Clinical Oncology, 24(2), 168-178., Doi: 10.1007/s10147-018-1338-8,
2. MIRILI C,YILMAZ A, DEMİRKAN S, et al.(2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. International Journal of Clinical Oncology, 24(10), 1301-1310., Doi: 10.1007/S10147-019-01461-7,
3. MIRILI C,PAYDAS S,KORKMAZ KAPUKAYA TUBA, YILMAZ A. (2019). Systemic immune- inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomarkers in Medicine, 13(18), 1565-1575., Doi: 10.2217/bmm-2019-0303,
4. MİRİLİ C,PAYDAS S,KILIÇ BAĞIR EMİNE,Şeydaoğlu gülşah,OĞUL ALİ,GOKCAY S,BUYUKSİMSEK M,yetisir abdullah evren,karaalioğlu bilgin,TOHUMCUO LU MERT,ERG N MELEK,ZORLUDEM R SUZAN (2020). Prognostic significance of EGFR, MUC1 and PD- L1 expressions in cases with triple negative breast cancer. Journal of BUON, 25(1), 159-167.
5. MİRİLİ C, PAYDAS S,GÜNEY iSA BURAK, OĞUL A,GOKCAY S,BÜYÜKSİMSEK MAHMUT,YetiSir Abdullah Evren, KARAALİOĞLU BİLGİN, TOHUMCUOĞLU MERT,SEYDAOĞLU GÜLŞAH (2019). Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study. Cancer Management and Research, 11, 3445-3453., Doi: 10.2147/CMAR.S191199,
6. YILMAZ A, MİRİLİ C, TEKİN SALİM BASOL, BİLİCİ M (2020). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. IRISH JOURNAL OF MEDICAL SCIENCE, 189(1), 91-102., Doi: 10.1007/s11845-019-02153-x,
7. YILMAZ A, MİRİLİ C, BİLİCİ M,TEKİN SALİM BAŞOL (2019). A Novel Predictor in Patients With Gastrointestinal Stromal Tumors: Systemic Immune-Inflammation Index (SII). Journal of BUON, 24(5), 2127-2135.
8. YILMAZ A, MİRİLİ C, BİLİCİ M,TEKİN SALİM BAŞOL (2020). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 35(2), 351-353, Doi: 10.1007/s00384-019-03454-4
9. Mirili C, Yilmaz A. (2020). Coexistence of anal malignant melanoma and papillary renal cell cancer: An interesting coexistence. Journal of Cancer Research and Therapeutics, 16(1), 189.
10. PAYDAS S,OĞUL A, MİRİLİ C, GÖKÇAY S. (2019). Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma. ANNALS OF HEMATOLOGY, 98(7), 1803-1803., Doi: 10.1007/S00277-019-03720-Z,
11. TATAR E, MİRİLİ C, IŞIKYAKAR T, GÜVERCİN G, ÖZAY E, AŞÇI G. (2016). The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clinica Belgica, 71(4), 221-226., Doi: 10.1080/17843286.2016.1159797,
12.BÜYÜKSİMSEK M, Togun M,KARA İO, BİŞGİN A,BOGA İ, TOHUMCUOĞLU M, OĞUL A, Yetisir AE, ŞAHİN B, MİRİLİ C (2019). Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey. Balkan Journal of Medical Genetics, 22(2), 17-24., Doi: 10.2478/bjmg-2019-0016,
13. MİRİLİ C, PAYDAS S, OĞUL A, GOKCAY S, BUYUKSİMSEK M, Yetisir AE , TOHUMCUOĞLU M, KaraalioĞlu B(2020). Dynamic Prognostic Nutritional Index could be a novel predictor of survival in Lung Cancer patients treated with nivolumab. The Annals of Clinical and Analytical Medicine, 11(supplement 1), 1-6., Doi: 10.4328/ACAM20025,
14. MİRİLİ C, YÜCE KÇ, YILMAZ A, BİLİCİ M, TEKİN SB, tatar A, YAKAR Ö, ERCOŞKUN P (2019). Clinical results and importance of next- generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery, 6(12), 327-332., Doi: 10.36472/msd.v6i12.330,
15. MİRİLİ C, BİLİCİ M (2020). Inflammatory prognostic markers in endometrial carcinoma: Systemic immune-inflammation index and prognostic nutritional index. Medical Science and Discovery, 7(1), 351-359., Doi: 10.36472/msd.v7i1.339
16. MİRİLİ C, PAYDAS S,OĞUL A,GOKCAY S (2018). Acute promyelocytic leukemia after anthracycline containing chemotherapy for breast cancer: Case report and review of the literature. Journal of Oncological Sciences, 4(1), 62-64., Doi: 10.1016/j.jons.2018.02.001,
17. MİRİLİ C, PAYDAS S,OĞUL A,GOKCAY S, BUYUKSİMSEK M,YETİŞİR EVREN, HANTA İ, ERGİN M, KILIÇ BAĞIR E, GÜNEY İB (2018). Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature. Journal of Oncological Sciences, 4(1), 56-59., Doi: 10.1016/j.jons.2018.03.002,
18. BUYUKSİMSEK M, PAYDAS S, GÜMÜRDÜLÜ D, MİRİLİ C, OĞUL A, yetiSir abdullah evren, TOHUMCUOĞLU M (2019). Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma. Turkish Journal of Hematology, 36(1), 60-61., Doi: 10.4274/tjh.galenos.2018.2018.0115,
19. SARER YBP, KocabaS G, MİRİLİ C, SUNER KA, AKŞİT M, Yürekli İ, Kutbay NÖ, Yıdırım B, Bozkaya G (2018). Circulating Lipocalin-2 Levels Are Associated With Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels In Type 2 Diabetic Patients. Journal of Endocrinology and Diabetes, 5(5), 1-7., Doi: 10.15226/2374-6890/5/5/001116, (
20. BUYUKSİMSEK M, KARA İO, yetisir abdullah evren, MİRİLİ C, GOKCAY S, OĞUL A,TOHUMCUOğLU M, SÜMBÜL HE, büyüksimsek k (2018). Metastatic Renal Cell Carcinoma Case Report Undergoing Multiple Treatment Options and Review of Literature . Eurasian Journal of Medical Investigation, 2(2), 101-103., Doi: 10.14744/ejmi.2018.76376,
21. PAYDA S, YETİSİR EVREN, MİRİLİ C, İSMAYİLOV ELÇİN, BÜYÜKSİMSEK M, OĞUL A, KILIÇ BE, ERGİN M (2018). G-CSF related hemophagocytos s in a case with lymhphoma. Clinical Research and Trials, 4(1), 1-2., Doi: 10.15761/CRT.1000203,
22. Ogul A, Paydas S, Doran F, Erdogan KE, Tohumcuoglu M, Buyuksimsek M, MİRİLİ C, Yetisir AE. (2021). The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer. Journal of BU ON.: Official Journal of the Balkan Union of Oncology, 26(3), 992-1001.
23. Buyuksimsek M, Kidi MM, Ogul A, Mirili C, Paydas S. (2021). The effect of inflammatory markers on survival in advanced biliary tract carcinoma treated with gemcitabine/Oxaliplatin regimen. Journal of Gastrointestinal Cancer, 52(1), 249-255.
B. ULUSAL HAKEMLİ DERGİLERDE YAYIMLANAN MAKALELER:
1. MİRİLİ C, YILMAZ AL, BİLİCİ M, TEKİN SB (2019). Servikal Kanser Hastalarinin Uzun Dönem Sonuçlari: Do u Anadolu Tek Merkez Deneyimi / Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey. Dicle T p Dergisi, 46(4), 857-865., Doi: 10.5798/dicletip.579312,
2. MİRİLİ C, PAYDAS S, BÜYÜKSİMSEK M, TOHUMCUOĞLU M, Yetisir abdullah evren, OĞUL A(2019). LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION. Nam k Kemal Medical Journal (NKMJ), 7(3), 271-278.,
3. MİRİLİ C, PAYDAS S,YILMAZ A, OĞUL A, BUYUKSİMSEK M, yetisir abdullah evren, TOHUMCUOĞLU M (2019). Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI). ACTA ONCOLOGICA TURCICA, 52(3), 372-378., Doi: 10.5505/aot.2019.08760,
4. BÜYÜKŞİMŞEK M, TOĞUN M, YETİŞİR AE, MİRİLİ C, OGUL A, TOHUMCUOĞLU M, PAYDAŞ S. LENFOMA HASTALARINDA HEPATİT B VE C PREVALANSININ DEĞERLENDİRİLMESİ. Namık Kemal Tıp Dergisi, 8(1), 48-51. doi.org/10.37696/nkmj.632911
5. SARER YÜREKL BANU PINAR, kocabaS gökçen, MİRİLİ C, Yürekli İsmail, çakır habib (2018). Is the ankle-brachial index directly associated with current glycemic control in diabetic patients?. Damar Cerrahi Dergisi, 27(3), 117-123., Doi: 10.9739/tjvs.2018.152,
6. iflazoğlu nidal, MİRİLİ C, karaalioğlu bilgin, DURAN A, çapkınoğlu emir, PARSAK CEM KAAN, ERDOğAN KE, AÇIKALIN A, DORAN F (2019). Primary Colon Lymphoma Presenting with Obstructive and Hemorrhagic Symptoms. Turkish Journal of Colorectal Disease, 29(1), 61-64., Doi: 10.4274/tjcd.galenos.2018.46762,
C. YAZILAN ULUSAL/ULUSLARARASI KİTAPLARDAKİ BÖLÜMLER:
1. Bölüm ad: RENAL HÜCREL KANSERDE İMMUNOTERAPİNİN YERİ VE ETKİNLİĞİ, 2018, ONKOLOJİDE GÜNCEL TEDAVİ YAKLAŞIMLARI-2, AKADEMİSYEN, Basım sayısı:1, Sayfa Sayısı 256, ISBN:978-605-258-373-9, Türkçe, (Bilimsel Kitap)
2. Bölüm ad: PANKREAS KANSERİNDE GÜNCEL TEDAVİ YAKLAŞIMLARI (2019), AKADEMiSYEN KiTABEVİ BİLİMSEL ARAŞTIRMALAR KİTABI-2018, AKADEMİSYEN, Basım sayısı:1, Sayfa Sayısı 360, ISBN:978- 605-258-068-4, Türkçe(Bilimsel Kitap),
3. Bölüm ad: MİDE KANSERİ TEDAVİSİNDE GÜNCEL ONKOLOJİK YAKLAŞIM (2022), AKADEMiSYEN KiTABEVİ, GASTROİNTESTİNAL SİSTEM KANSERLERİNDE GÜNCEL YAKLAŞIMLAR KİTABI-2022, AKADEMSİYEN, Basım sayısı:1, Sayfa 147, ISBN: 978-625-8430-27-1, Türkçe (Bilimsel Kitap)
D. D. ULUSLARARASI BİLİMSEL TOPLANTILARDA
SUNULAN VE BİLDİRİ KİTAPLARINDA (PROCEEDİNGS) BASILAN BİLDİRİLER :
1. MİRİLİ C, YILMAZ
A (2019). Stage is the predictor of prognosis in Classic Kaposi Sarcoma. 6th
MediterraneanMultidisciplinary Oncology Forum (MMOF) Congress” and “3rd
InternationalCongress on Oncological Sciences, (Özet bildiri),
2. BUYUKSİMSEK M, MİRİLİ C (2019). Meme Kanseri Hastalar nda D Vitamini Düzeyleri ve
Dislipideminin ncelenmesi. V. International Congress onNatural and Health
Sciences(ICNHS-2019), (Özet bildiri),
3. YILDIRIM alper, KORKMAZ KAPUKAYA TUBA,
MİRİLİ C, SÜMBÜL HE, taktakoğlu
onur, GÜVENÇ B (2015). ONE MORE FINGER IN A PATIENT WITH SEVERE ANEMIA. VI.
International Eurasian Congress of Hematology, 39(null), 52-53., (Özet
bildiri),
4. SARER
YÜREKLİ BANU PINAR, kocabas ünal gökçen, MİRİLİ
C, Yürekli İsmail, ÇAKIR HABİB
(2014). Is the ankle-brachial index directly associated with current
glycemic control in diabetic patients? Preliminary results of our study. 16th
European Congress of Endocrinology, Doi: 10.1530/endoabs.35.P406, (Özet
bildiri),
5. SARER
YÜREKLİ BANU PINAR, kocabas ünal gökçen, AKKAYA A, MİRİLİ C, ÜNAL S, GÜVERC N GÜRAY, ERDOĞAN M (2014). Serum
Dehydroepiandrosterone Sulfate Levels in Premenopausal Women with Chronic
Lymphocytic Thyroidtis. 16th the International Congress of Endocrinology (ICE)
and 96thThe Endocrine Society’s Annual Meeting Expo (ENDO), 35(3), (Özet
bildiri),
6. OĞUL A, ŞAHİN BERKSOY, KU CU FER
T,taktakoĞlu onur,yetiŞir abdullah evren, BUYUKSİMSEK M, MİRİLİ C, GOKCAY S, gök mehmet gökhan,kum pınar (2017). The
Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte
Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer.
2017 Adana Hepatocellular Carcinoma (HCC) Conference, 48(3), 286-287., Doi:
10.1007/s12029-017-9970-5, (Özet bildiri),
E. E. ULUSAL BİLİMSEL TOPLANTILARDA SUNULAN
VE BİLDİRİ KİTAPLARINDA BASILAN BİLDİRİLER:
1. MİRİLİ C (2019).
METASTATİK KOLOREKTAL KANSERDE RAS MUTASYONU SIKLIĞI BÖLGESEL FARKLILIKLAR
GÖSTERİYOR MU?. KONYA MULTİDİSİPLİNER ONKOLOJ SEMPOZYUMU,
2. MİRİLİ C (2019).
İLER EVRE PANKREAS KANSERİNDE YENİ BİR BELİRTEÇ: HEMOGLOBİNİN KIRMIZI KAN
HÜCRES DAĞILIM GENİŞLİĞİNE ORANI (HRO). ONKOLOJİDE İZ BIRAKANLAR ZİRVESİ ,
3. MİRİLİ C, YAKAR
ÖMER (2019). MEME VE/VEYA OVER KANSERL HASTALARIMIZDA YEN NESİL SEKANSLAMA
YÖNTEMİLE SAPTANAN PATOJENİK MUTASYONLAR. 15. ULUSAL MEME HASTALIKLARI KONGRESİ
,
4. MİRİLİ C, YILMAZ
A (2019). Factors Predicting Survival in our Patients with Thyroid Cancer /
Tiroit kanseri hastalar m zda ya am sürelerini predikte eden faktörler. 3.
Ulusal mmünoterapi ve Onkoloji Kongresi, 72-72., Doi: 10.14744/ejmo.2019.2019,
5. MİRİLİ C, PAYDAS
S,GÜNEY İSA BURAK (2018). NİVOLUMAB: 3. YIL ERKEN ER M PROGRAMI VERİLER . VIII.
Ulusal Akciğer Kanseri Kongresi,
6. MİRİLİ C, PAYDAS
S,GÜNEY iSA BURAK, SEYDAOğLU GÜLşAH, KAPUKAYA TUBA KORKMAZ, OĞUL A,GOKCAY S
(2018). KÜÇÜK HÜCRELi AKCiğER KANSERİNDE (KHAK) NÖTROFİL LENFOSİT ORANI (NLO) İLE
PET-CT’DE SAPTANAN METABOLİK PARAMETRELERİNİN (PET-CT MP) PROGNOSTİK ÖNEMİVE
NLO İLE PET-CT MP İLİŞKİSİ. 7.Türk Tibbi Onkoloji Kongresi,
7. BÜYÜKSİMSEK MAHMUT, yetisir abdullah
evren, OĞUL A,GOKCAY S, MİRİLİ C, PAYDAS
S (2017). RAI TEDAViSİ SONRASI GELİŞEN EOZİNOFİLİK MYELOİD NEOPLAZİ VE
LENFOBLASTİK LENFOMA BİRLİKTELİĞİ 22. ULUSAL KANSER KONGRESİ,
8. GOKCAY S, ŞAHİN BERKSOY, OĞUL A, MİRİLİ C, BUYUKSİMSEK M, yetiSir
abdullah evren (2017). GEBELİKLE İLİŞKİSİZ
GESTASYONEL TROFOBLAST K TÜMÖR: VAKA SUNUMU. 22. ULUSAL KANSER KONGRES
9. OĞUL A, PAYDAS S, yetiSir abdullah
evren, MİRİLİ C, BUYUKSİMSEK M, GOKCAY
S (2017). Prephase tedavinin yüksek tümör yükü olan lenfomal hastalarda tümör
lizis sendromunu önlemede etkinliĞi.. Ulusal mmunoterapi ve Onkoloji Kongresi,
10. OĞUL A,PAYDAS S, yetiSir abdullah
evren, BUYUKSİMSEK M,MİRİLİ C
(2017). Paratiroid karsinomlu, hiperkalsemik hastada peruktan alkol enjeksiyonu
seçeneĞi. Ulusal mmunoterapi ve Onkoloji Kongresi,
11. BUYUKSİMSEK M, yetiSir abdullah evren,
OĞUL A, GOKCAY S, MİRİLİ C, ŞAHİN
BERKSOY (2017). ANAPLASTİK PLAZMA HÜCRE NEOPLAZİSİ ŞEKLİNDE PREZENTE OLAN POEMS
SENDROMU. 22. ULUSAL KANSER KONGRESİ,
12. YetiSir abdullah evren, BUYUKSİMSEK M, OĞUL A, GOKCAY S, MİRİLİ C, ŞAHİN BERKSOY (2017). İNGUİNAL BÖLGEDE İNFLAMATUAR MYOFBROBLASTİK TÜMÖR OLGU SUNUMU. 22. ULUSAL KANSER KONGRESİ,